WO2011007551A1 - Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria - Google Patents
Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria Download PDFInfo
- Publication number
- WO2011007551A1 WO2011007551A1 PCT/JP2010/004530 JP2010004530W WO2011007551A1 WO 2011007551 A1 WO2011007551 A1 WO 2011007551A1 JP 2010004530 W JP2010004530 W JP 2010004530W WO 2011007551 A1 WO2011007551 A1 WO 2011007551A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sugar alcohol
- antibacterial agent
- growth
- maltitol
- antibacterial
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Definitions
- the present invention relates to an antibacterial agent comprising sugar alcohols, particularly lactol and maltitol.
- Sugar alcohol is low in calories, has non-cariogenic properties, and is used in a wide range of products such as foods, cosmetics, pharmaceuticals, and health foods from the viewpoint of preventing tooth decay and lifestyle-related diseases.
- products such as foods, cosmetics, pharmaceuticals, and health foods from the viewpoint of preventing tooth decay and lifestyle-related diseases.
- the growth inhibitory action against the causative bacteria of dental caries is widely known, but many other usefulness are still unclear.
- Non-patent document 1 reports the effect of xylitol on the growth inhibition of P. gingivalis.
- sugar alcohols other than xylitol have not been reported at all regarding antibacterial or growth inhibition against periodontal pathogens, except for causative bacteria and Candida.
- Patent Document 1 discloses a preventive or therapeutic agent for periodontal disease.
- lactic acid bacteria are mixed and inoculated with P. gingivalis in a medium containing sugars that can be assimilated by these bacteria, thereby suppressing the growth of P. gingivalis compared to the medium alone.
- the comparison of the proliferation of the culture medium containing saccharides and the culture medium not containing is not performed.
- glucose, lactose, and sucrose are used as sugars, and only P. gingivalis is used as a test strain.
- claim 2 separately describes xylitol, erythritol, and maltitol as sugars, and Prevotella intermedia, Actinobacillus actinomycetemcomitans, Candida, and mutans as control periodontal pathogens in the embodiment of the invention.
- xylitol, erythritol, and maltitol as sugars
- Prevotella intermedia, Actinobacillus actinomycetemcomitans, Candida, and mutans as control periodontal pathogens in the embodiment of the invention.
- Patent Document 2 discloses a composition for preventing and / or treating oral disease.
- xylitol By adding xylitol to the medium containing the culture filtrate of lactic acid bacteria, the growth of P. gingivalis, F. nucleatum, P. intermedia, and Actinobacillus actinomycetemcomitans is suppressed compared to the culture filtrate alone condition.
- the addition of xylitol alone to the medium has little effect on the growth of these bacteria.
- the growth of P. gingivalis is also suppressed by adding erythritol or maltitol.
- Patent Document 3 discloses a live bacterial preparation containing lactic acid bacteria as an active ingredient and a food containing lactic acid bacteria.
- erythritol was added to the basal medium to a final concentration of 5% and Streptococcus mutans was cultured for 24 hours, the number of viable cells was suppressed by 75% and the amount of insoluble glucan formed was suppressed by 60% compared to the condition where erythritol was not added. Yes.
- lactic acid bacteria are cultured simultaneously, the degree of suppression is further increased.
- sugar alcohol contains only erythritol in the composition. However, there is no report of antibacterial action against periodontal pathogens by sugar alcohol alone.
- Sugar alcohol is used in a wide range of products such as foods, cosmetics, pharmaceuticals and health foods, and its anti-proliferative action against causative bacteria in the oral cavity is widely known, but other usefulness has not been elucidated. Many.
- periodontal pathogens were cultured in a medium containing lactitol or maltitol, it was confirmed that the growth was significantly inhibited as compared with a medium not containing lactitol or maltitol. Moreover, it was suggested that this effect is not bactericidal but may be bacteriostatic.
- the present invention has an antibacterial action against periodontal pathogens, as a preparation such as a mouthwash, a toothpaste, an inhalant, a troche, etc., chewing gum, candy, tablet candy, gummy jelly, biscuits, It can be used and consumed on a daily basis as foods such as chocolate and other confectionery, sherbet and beverages, and is extremely effective in improving and preventing periodontal disease and touch.
- One embodiment of the present invention is an antibacterial agent for periodontal pathogen growth inhibition containing sugar alcohol as an active ingredient.
- a further embodiment of the present invention is an antibacterial agent for inhibiting periodontal pathogen growth containing lactitol or maltitol as an active ingredient.
- Another embodiment of the present invention is a mouthwash, a toothpaste, an inhalant, and a troche made of an antibacterial agent for inhibiting periodontal pathogen growth containing lactitol or maltitol as an active ingredient.
- Still another embodiment of the present invention is a chewing gum, candy, tablet confectionery, gummy jelly, biscuits, chocolate and other confectionery, sherbet, containing an antibacterial agent for inhibiting periodontal pathogen growth containing lactitol or maltitol as an active ingredient , Food such as beverages.
- Example 1 The antibacterial test of sugar alcohol was performed as follows.
- Test sample preparation method Using 2% ethanol, the final medium concentration is 8% for xylitol, erythritol, lactitol, maltitol, the final medium concentration is 800 ppm for thymol, and the final medium concentration is 200 ppm for zinc chloride. Each was prepared and a 2-fold dilution series was prepared with 2% ethanol.
- T. gingivalis Porphyromonas gingivalis ATCC33277 (hereinafter abbreviated as P. gingivalis), Fusobacterium nucleatum ATCC25586 (hereinafter abbreviated as F.nucleatum), Prevotella intermedia ATCC25611 (hereinafter abbreviated as P.intermedia), Prevotella nigrescens JCM6322 strain (hereinafter abbreviated as P. nigrescens), Treponema denticola ATCC35405 strain (hereinafter abbreviated as T.denticola), Tannerella forsythia JCM10827 strain (hereinafter abbreviated as T.
- oral bacteria with a high percentage in tongue coating are Prevotella melaninogenica JCM6325 strain (hereinafter abbreviated as P. melaninogenica), Veillonella parvula JCM12972 strain (hereinafter abbreviated as V. parvula), and Veillonella dispar ATCC17748 strain. (Hereinafter abbreviated as V.dispar).
- V.parvula and V.dispar are Trypticase (5.0g / l), Yeast Extract (3.0g / l), Sodium lactate (9.0g / l), Sodium thioglycollate (0.75g / l), Tween80 (1.0g / l) , Glucose (1.0 g / l) added medium was adjusted to pH 7.5 with K 2 CO 2 and cultured under the same conditions.
- T. forsythia was prepared by sterilizing Brain heart infusion broth supplemented with Yeast extract (5.0 g / l), Hemin (5.0 mg / l) and Menadione (0.5 mg / l) at 120 ° C.
- L-cysteine 1.0 g / l
- N-acetylneuraminic acid 10.0 mg / l
- Fetal Bovine Serum 50 ml / l
- the antibacterial property test used a liquid dilution method in which dilution was performed in a 2-fold dilution series. That is, a test sample solution that has been diluted 2 times is added to a 96-well plate (the volume of each well is 100 ⁇ l), and the bacterial solution cultured in the above 1-3 medium is added to the same medium at a concentration of 5% or less. After dilution and mixing, 100 ⁇ l of this was added to a 96-well plate.
- MIC minimum growth inhibitory concentration
- Table 1 shows the MIC of each test strain. All test samples showed no antibacterial activity against P. nigrescens, P. melaninogenica, V. parvula, T. forsythia at concentrations of 8% or less (thymol 800 ppm or less). Although antibacterial activity was not obtained with thymol against T. denticola, an MIC of 8% was confirmed for all four sugar alcohols used in the test. Conversely, thymol showed a MIC of 400 ppm for V.dispar, but sugar alcohol did not show antibacterial activity. In addition, the activity against P. gingivalis was weak compared to 25 ppm for zinc chloride and 200 ppm for thymol, but weak antibacterial activity was confirmed for all sugar alcohols.
- Zinc chloride was tested for antibacterial activity only against P. gingivalis. Although it was less active against F. nucleatum compared to 200 ppm of thymol, xylitol and erythritol showed an MIC of 8%. Although antibacterial activity was not confirmed with thymol against P.intermedia, erythritol showed an MIC of 8%.
- Example 2 A sugar alcohol growth inhibition test was performed as follows.
- Test Sample Preparation Method For xylitol, erythritol, lactitol and maltitol, the final medium concentration was adjusted to 5% or 10%.
- test strain F. nucleatum and P. gingivalis described in the test strain of Example 1 were used.
- xylitol and erythritol showed particularly strong growth inhibition. This result correlates with the result of antibacterial test against F. nucleatum.
- Both sugar alcohols showed OD 660 values lower than the control at the time of culturing 44 hours at 5% and 10% concentrations. Lactitol and maltitol showed the same growth as the control at 5% concentration, but showed a lower OD 660 value at 10% concentration than the control at 44 hours after culturing.
- Lactitol and maltitol showed particularly strong growth inhibition against P. gingivalis.
- a mouthwash containing a periodontal pathogen growth inhibitory antibacterial agent comprising the sugar alcohol of the present invention, toothpaste, spray for bad breath, troche, chewing gum, candy, tablet confectionery, gummy jelly, and beverage were produced by conventional methods. .
- Their formulations are shown below. Note that the scope of the present invention is not limited by these.
- Example 3 A mouthwash was prepared according to the following formulation. Ethanol 2.0% by weight Lactitol 10.0 Fragrance 1.0 Water remaining 100.0
- Example 4 A toothpaste was produced according to the following formulation. Calcium carbonate 40.0% by weight Glycerin 10.0 Maltitol 20.0 Carboxymethylcellulose 2.0 Sodium ralyl sulfate 2.0 Fragrance 1.0 Saccharin 0.1 Chlorhexidine 0.01 Water remaining 100.0
- Example 5 A spray for halitosis was produced according to the following formulation. Ethanol 10.0% by weight Glycerin 5.0 Lactitol 10.0 Maltitol 10.0 Fragrance 0.05 Coloring 0.001 Water remaining 100.0
- Example 6 A lozenge was produced according to the following formulation. Maltitol 72.3 wt% Xylitol 20.0 Gum arabic 6.0 Fragrance 1.0 Sodium monofluorophosphate 0.7 100.0
- Chewing gum was manufactured according to the following formulation. Gum base 20.0% by weight Maltitol 45.0 Lactitol 33.0 Fragrance 2.0 100.0
- Example 8 Candy was manufactured according to the following prescription. Maltitol 50.0% by weight Reduced water candy 34.0 Citric acid 2.0 Fragrance 0.2 Water remaining 100.0
- Example 9 Tablet confectionery was produced according to the following prescription. Maltitol 76.1% by weight Lactitol 19.0 Sucrose fatty acid ester 0.2 Fragrance 0.2 Water 4.5 100.0
- Example 10 Gummy jelly was manufactured according to the following prescription. Gelatin 60.0% by weight Reduced water candy 21.40 Maltitol 11.5 Vegetable oil 4.5 Malic acid 2.0 Fragrance 0.5 100.0
- Example 11 A beverage was produced according to the following formulation. Orange juice 30.0% by weight Lactitol 15.0 Citric acid 0.1 Vitamin C 0.04 Fragrance 0.1 Water remaining 100.0
- the sugar alcohol according to the present invention is a widely used material, and is useful for various products using the sugar alcohol, in particular, foods for preventing periodontal diseases.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
糖アルコールの抗菌性試験を以下のように行った。 Example 1
The antibacterial test of sugar alcohol was performed as follows.
2%エタノールを用いて、キシリトール、エリスリトール、ラクチトール、マルチトールについては最終培地濃度が8%、チモールについては最終培地濃度が800ppm、塩化亜鉛については最終培地濃度が200ppmとなるようそれぞれ調製し、2%エタノールにより2倍希釈系列を作製した。 1-1. Test sample preparation method Using 2% ethanol, the final medium concentration is 8% for xylitol, erythritol, lactitol, maltitol, the final medium concentration is 800 ppm for thymol, and the final medium concentration is 200 ppm for zinc chloride. Each was prepared and a 2-fold dilution series was prepared with 2% ethanol.
歯周病原菌としてPorphyromonas gingivalis ATCC33277株(以後P.gingivalisと略す)、Fusobacterium nucleatum ATCC25586株(以後F.nucleatumと略す)、Prevotella intermedia ATCC25611株(以後P.intermediaと略す)、Prevotella nigrescens
JCM6322株(以後P.nigrescensと略す)、Treponema denticola
ATCC35405株(以後T.denticolaと略す)、Tannerella forsythia
JCM10827株(以後T.forsythiaと略す)を用いた。また、舌苔局在菌のなかで、舌苔における割合が高い口腔内細菌として、Prevotella melaninogenica JCM6325株(以後P.melaninogenicaと略す)、Veillonella parvula JCM12972株(以後V.parvulaと略す)、Veillonella dispar ATCC17748株(以後V.disparと略す)を用いた。 1-2. Test strains As the periodontal pathogens, Porphyromonas gingivalis ATCC33277 (hereinafter abbreviated as P. gingivalis), Fusobacterium nucleatum ATCC25586 (hereinafter abbreviated as F.nucleatum), Prevotella intermedia ATCC25611 (hereinafter abbreviated as P.intermedia), Prevotella nigrescens
JCM6322 strain (hereinafter abbreviated as P. nigrescens), Treponema denticola
ATCC35405 strain (hereinafter abbreviated as T.denticola), Tannerella forsythia
JCM10827 strain (hereinafter abbreviated as T. forsythia) was used. In addition, among oral tongue bacteria, oral bacteria with a high percentage in tongue coating are Prevotella melaninogenica JCM6325 strain (hereinafter abbreviated as P. melaninogenica), Veillonella parvula JCM12972 strain (hereinafter abbreviated as V. parvula), and Veillonella dispar ATCC17748 strain. (Hereinafter abbreviated as V.dispar).
P.gingivalis、F.nucleatum、P.intermedia、P.nigrescens、P.melaninogenicaはYeast extract(3.0g/l)、Hemin (5.0mg/l)、Menadione(0.5mg/l)を添加したTripticase soy brothを用いて、37℃の嫌気条件下(10%CO2、10%H2、80%N2)で培養した。V.parvula、 V.disparはTrypticase(5.0g/l)、Yeast Extract(3.0g/l)、Sodium lactate(9.0g/l)、Sodium thioglycollate(0.75g/l)、Tween80(1.0g/l)、Glucose (1.0g/l)を加えた培地をK2CO2でpH7.5に調製し、同様の条件で培養した。T.forsythiaはYeast extract(5.0g/l)、Hemin(5.0mg/l)、Menadione(0.5mg/l)を添加したBrain heart infusion brothを120℃、15分滅菌処理した後、L-cysteine(1.0g/l)、N-acetylneuraminic acid(10.0mg/l)、Fetal Bovine Serum(50ml/l)を添加した培地を用いて同条件で培養した。T.denticolaはTYGVS培地を用いて同様の条件で培養した。 1-3. Media P.gingivalis, F.nucleatum, P.intermedia, P.nigrescens, P.melaninogenica are Tripticase soy supplemented with Yeast extract (3.0 g / l), Hemin (5.0 mg / l), Menadione (0.5 mg / l) Using broth, the cells were cultured under anaerobic conditions (10% CO 2 , 10% H 2 , 80% N 2 ) at 37 ° C. V.parvula and V.dispar are Trypticase (5.0g / l), Yeast Extract (3.0g / l), Sodium lactate (9.0g / l), Sodium thioglycollate (0.75g / l), Tween80 (1.0g / l) , Glucose (1.0 g / l) added medium was adjusted to pH 7.5 with K 2 CO 2 and cultured under the same conditions. T. forsythia was prepared by sterilizing Brain heart infusion broth supplemented with Yeast extract (5.0 g / l), Hemin (5.0 mg / l) and Menadione (0.5 mg / l) at 120 ° C. for 15 minutes, and then L-cysteine ( 1.0 g / l), N-acetylneuraminic acid (10.0 mg / l), and Fetal Bovine Serum (50 ml / l) were added under the same conditions. T. denticola was cultured under the same conditions using TYGVS medium.
抗菌性試験は2倍希釈系列で希釈を行った液体希釈法を用いた。すなわち、2倍希釈系列を行った被験試料液を96穴プレートに加え (各穴の液量は100μl)、前記1-3の培地で培養した菌液を同一の培地に5%以下の濃度で希釈・混和し、これを96穴プレート上に100μl添加した。尚、菌液を含まない100μlの培地のみを添加したものをコントロールとし、24~48時間の嫌気培養(10%CO2、10%H2、80%N2)を行い、分光光度計にてOD660値を測定した。コントロールと比較してOD660値が同程度のもの、かつ肉眼で菌の発育が認められない濃度を最小発育阻止濃度(以後MICと略す)とした。 1-4. Determination of antibacterial property The antibacterial property test used a liquid dilution method in which dilution was performed in a 2-fold dilution series. That is, a test sample solution that has been diluted 2 times is added to a 96-well plate (the volume of each well is 100 μl), and the bacterial solution cultured in the above 1-3 medium is added to the same medium at a concentration of 5% or less. After dilution and mixing, 100 μl of this was added to a 96-well plate. In addition, as a control, add only 100 μl of medium without bacterial solution, and perform anaerobic culture (10% CO 2 , 10% H 2 , 80% N 2 ) for 24 to 48 hours, using a spectrophotometer The OD 660 value was measured. The concentration at which the OD 660 value was comparable to that of the control and the growth of bacteria was not observed with the naked eye was defined as the minimum growth inhibitory concentration (hereinafter abbreviated as MIC).
各種糖アルコールの口臭原因菌に対する抗菌活性を確認する目的で抗菌試験を行った。 1-5. Results Antibacterial tests were conducted for the purpose of confirming the antibacterial activity of various sugar alcohols against bad breath causing bacteria.
ND:No Data
糖アルコール濃度:0.0078%~8%
チモール濃度:0.78ppm~800ppm
塩化亜鉛濃度:0.195ppm~200ppm
ND: No Data
Sugar alcohol concentration: 0.0078%-8%
Thymol concentration: 0.78ppm-800ppm
Zinc chloride concentration: 0.195ppm to 200ppm
糖アルコールの増殖抑制試験を以下のように行った。 (Example 2)
A sugar alcohol growth inhibition test was performed as follows.
キシリトール、エリスリトール、ラクチトール、マルチトールについて最終培地濃度が5%または10%となるよう調製した。 2-1. Test Sample Preparation Method For xylitol, erythritol, lactitol and maltitol, the final medium concentration was adjusted to 5% or 10%.
菌株としては、実施例1の供試菌株に記載のF.nucleatumとP.gingivalisを用いた。 2-2. As the test strain, F. nucleatum and P. gingivalis described in the test strain of Example 1 were used.
P.gingivalis、F.nucleatum共にYeast extract(3.0g/l)、Hemin(5.0mg/l)、Menadione(0.5mg/l)を添加したTripticase soy brothを用いて、37℃の嫌気条件下(10%CO2、10%H2、80%N2)で培養した。増殖曲線測定時は上記培地に最終濃度5%または10%となるよう糖アルコールを添加、溶解後、120℃、15分滅菌処理したものを用いた。 2-3. Medium P.gingivalis, F.nucleatum both Yeast extract (3.0 g / l), Hemin (5.0 mg / l), Tripticase soy broth supplemented with Menadione (0.5 mg / l), under anaerobic conditions at 37 ° C ( 10% CO 2 , 10% H 2 , 80% N 2 ). When measuring the growth curve, sugar alcohol was added to the above medium to a final concentration of 5% or 10%, dissolved, and then sterilized at 120 ° C. for 15 minutes.
前記2-3の培地で対数増殖期まで培養した菌液を、5%または10%の各糖アルコールを含む培地20mlに100μl添加した。尚、糖アルコールを含まない通常の培地20mlに菌液100μlを添加したものをコントロールとした。40~47時間の嫌気培養(10%CO2、10%H2、80%N2)を行い、その間、分光光度計にてOD660値を適時測定した。 2-4. Measurement of Growth Curve 100 μl of the bacterial solution cultured in the above 2-3 medium until the logarithmic growth phase was added to 20 ml of a medium containing 5% or 10% of each sugar alcohol. As a control, 20 ml of a normal medium containing no sugar alcohol was added with 100 μl of the bacterial solution. Anaerobic culture (10% CO 2 , 10% H 2 , 80% N 2 ) was performed for 40 to 47 hours, and OD 660 value was measured with a spectrophotometer during this time.
抗菌試験において、P.gingivalis、 F.nucleatum等4菌株に対して抗菌活性が認められたことから、糖アルコールがこれら菌株に対して増殖を抑制する可能性が示唆された。この可能性を確認する目的で、糖アルコールを含有した培地におけるP.gingivalis、 F.nucleatumの増殖曲線の測定を行った。F.nucleatumの増殖曲線を図1A、1B、1C及び1Dに、P.gingivalisの増殖曲線を図2A、2B、2C及び2Dに示す。なお、各糖アルコールについて、n=2(図中では1、2と表記)で試験を行い、コントロールは糖アルコール無添加培地を示す。 2-5. Results In the antibacterial test, antibacterial activity was observed against 4 strains such as P. gingivalis, F. nucleatum, etc., suggesting the possibility that sugar alcohol could inhibit the growth of these strains. In order to confirm this possibility, the growth curves of P. gingivalis and F. nucleatum were measured in a medium containing sugar alcohol. The growth curves of F. nucleatum are shown in FIGS. 1A, 1B, 1C and 1D, and the growth curves of P. gingivalis are shown in FIGS. 2A, 2B, 2C and 2D. Each sugar alcohol was tested at n = 2 (denoted as 1 and 2 in the figure), and the control represents a sugar alcohol-free medium.
10%キシリトールにはばらつきが見られ、再現性を確認する必要があるが、キシリトール、エリスリトールには、対数増殖期に移行する時間を遅延させる効果があると考えられる。 In both sugar alcohols at 5% and 10% concentrations, no growth was observed even after 40 hours of culturing, and the culture solution was transparent even when visually confirmed. In addition, although the effects of xylitol and erythritol varied, they showed weak growth inhibition. Both sugar alcohols showed bacterial growth from around 20 hours of culture, and showed an OD 660 value similar to that of the control after 46 hours. For lactitol and maltitol, there was a possibility that the bacteria were killed due to the influence of water activity, so apply 10% lactitol and 10% maltitol culture solution 100 μl after 40 hours of culture to the blood plate medium, The cells were cultured for 10 days under anaerobic conditions (10% CO 2 , 10% H 2 , 80% N 2 ) at 37 ° C. As a result, 83 colonies were confirmed under 10% lactitol conditions and 308 colonies under 10% maltitol conditions, suggesting that both sugar alcohols may act bacteriostatically rather than bactericidally.
Variations are seen in 10% xylitol, and reproducibility needs to be confirmed, but xylitol and erythritol are thought to have the effect of delaying the time to transition to the logarithmic growth phase.
下記処方に従って含そう剤を製造した。
エタノール 2.0重量%
ラクチトール 10.0
香料 1.0
水 残
100.0 (Example 3)
A mouthwash was prepared according to the following formulation.
Ethanol 2.0% by weight
Lactitol 10.0
Fragrance 1.0
Water remaining
100.0
下記処方に従って練り歯磨きを製造した。
炭酸カルシウム 40.0重量%
グリセリン 10.0
マルチトール 20.0
カルボオキシメチルセルロース 2.0
ラルリル硫酸ナトリウム 2.0
香料 1.0
サッカリン 0.1
クロルヘキシジン 0.01
水 残
100.0 Example 4
A toothpaste was produced according to the following formulation.
Calcium carbonate 40.0% by weight
Glycerin 10.0
Maltitol 20.0
Carboxymethylcellulose 2.0
Sodium ralyl sulfate 2.0
Fragrance 1.0
Saccharin 0.1
Chlorhexidine 0.01
Water remaining
100.0
下記処方に従って口臭用スプレーを製造した。
エタノール 10.0重量%
グリセリン 5.0
ラクチトール 10.0
マルチトール 10.0
香料 0.05
着色料 0.001
水 残
100.0 (Example 5)
A spray for halitosis was produced according to the following formulation.
Ethanol 10.0% by weight
Glycerin 5.0
Lactitol 10.0
Maltitol 10.0
Fragrance 0.05
Coloring 0.001
Water remaining
100.0
下記処方に従ってトローチを製造した。
マルチトール 72.3重量%
キシリトール 20.0
アラビアガム 6.0
香料 1.0
モノフルオロリン酸ナトリウム 0.7
100.0 (Example 6)
A lozenge was produced according to the following formulation.
Maltitol 72.3 wt%
Xylitol 20.0
Gum arabic 6.0
Fragrance 1.0
Sodium monofluorophosphate 0.7
100.0
下記処方に従ってチューインガムを製造した。
ガムベース 20.0重量%
マルチトール 45.0
ラクチトール 33.0
香料 2.0
100.0 (Example 7)
Chewing gum was manufactured according to the following formulation.
Gum base 20.0% by weight
Maltitol 45.0
Lactitol 33.0
Fragrance 2.0
100.0
下記処方に従ってキャンディを製造した。
マルチトール 50.0重量%
還元水あめ 34.0
クエン酸 2.0
香料 0.2
水 残
100.0 (Example 8)
Candy was manufactured according to the following prescription.
Maltitol 50.0% by weight
Reduced water candy 34.0
Citric acid 2.0
Fragrance 0.2
Water remaining
100.0
下記処方に従って錠菓を製造した。
マルチトール 76.1重量%
ラクチトール 19.0
ショ糖脂肪酸エステル 0.2
香料 0.2
水 4.5
100.0 Example 9
Tablet confectionery was produced according to the following prescription.
Maltitol 76.1% by weight
Lactitol 19.0
Sucrose fatty acid ester 0.2
Fragrance 0.2
Water 4.5
100.0
下記処方に従ってグミゼリーを製造した。
ゼラチン 60.0重量%
還元水あめ 21.40
マルチトール 11.5
植物油脂 4.5
リンゴ酸 2.0
香料 0.5
100.0 (Example 10)
Gummy jelly was manufactured according to the following prescription.
Gelatin 60.0% by weight
Reduced water candy 21.40
Maltitol 11.5
Vegetable oil 4.5
Malic acid 2.0
Fragrance 0.5
100.0
下記処方に従って飲料を製造した。
オレンジ果汁 30.0重量%
ラクチトール 15.0
クエン酸 0.1
ビタミンC 0.04
香料 0.1
水 残
100.0 (Example 11)
A beverage was produced according to the following formulation.
Orange juice 30.0% by weight
Lactitol 15.0
Citric acid 0.1
Vitamin C 0.04
Fragrance 0.1
Water remaining
100.0
Claims (7)
- 糖アルコールを有効成分とする歯周病原菌増殖抑制抗菌剤。 An antibacterial agent for periodontal pathogen growth inhibition containing sugar alcohol as an active ingredient.
- 前記糖アルコールが、ラクチトールまたはマルチトールである、請求項1に記載の抗菌剤。 The antibacterial agent according to claim 1, wherein the sugar alcohol is lactitol or maltitol.
- 請求項1または2に記載の抗菌剤からなる含そう剤。 A mouthwash comprising the antibacterial agent according to claim 1 or 2.
- 請求項1または2に記載の抗菌剤からなる練り歯磨き剤。 A toothpaste comprising the antibacterial agent according to claim 1 or 2.
- 請求項1または2に記載の抗菌剤からなる吸入剤。 An inhalant comprising the antibacterial agent according to claim 1 or 2.
- 請求項1または2に記載の抗菌剤からなるトローチ剤。 A lozenge comprising the antibacterial agent according to claim 1 or 2.
- 請求項1または2に記載の抗菌剤を含有する食品。 Food containing the antibacterial agent according to claim 1 or 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010800297408A CN102470113A (en) | 2009-07-14 | 2010-07-13 | Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-165554 | 2009-07-14 | ||
JP2009165554A JP5710111B2 (en) | 2009-07-14 | 2009-07-14 | Antibacterial agent consisting of lactitol and maltitol |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011007551A1 true WO2011007551A1 (en) | 2011-01-20 |
Family
ID=43449161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/004530 WO2011007551A1 (en) | 2009-07-14 | 2010-07-13 | Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5710111B2 (en) |
KR (1) | KR20120042968A (en) |
CN (1) | CN102470113A (en) |
TW (1) | TW201117804A (en) |
WO (1) | WO2011007551A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015084314A1 (en) * | 2013-12-02 | 2015-06-11 | Colgate-Palmolive Company | Oral care zinc compositions |
WO2015099755A1 (en) * | 2013-12-27 | 2015-07-02 | Colgate-Palmolive Company | Prebiotic oral care methods using a saccharide |
WO2023199057A1 (en) * | 2022-04-13 | 2023-10-19 | Brunel University London | Compositions for preventing and treating infection comprising an artificial sweetener |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002512966A (en) * | 1998-04-28 | 2002-05-08 | ジューズッカー アクティエンゲゼルシャフト | Cold remedy containing isomalt as active ingredient |
JP2008148614A (en) * | 2006-12-17 | 2008-07-03 | Shuhei Higashimatsu | Pudding-like food product |
JP2008283964A (en) * | 2007-04-19 | 2008-11-27 | Lion Corp | Sugar-coated chewing gum composition and method for producing sugar-coated chewing gum |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5697215A (en) * | 1979-12-29 | 1981-08-05 | Lion Corp | Composition for oral cavity application |
JPS56118012A (en) * | 1980-02-23 | 1981-09-16 | Lion Corp | Composition for oral cavity |
JP3763075B2 (en) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | Food composition, oral composition and pharmaceutical composition for prevention or treatment of periodontal disease |
JP4873805B2 (en) * | 2001-09-07 | 2012-02-08 | 小林製薬株式会社 | Anti-periodontal agent |
JP4528472B2 (en) * | 2001-11-29 | 2010-08-18 | ビオフェルミン製薬株式会社 | Preventive or therapeutic agent for periodontal disease |
JP2006282562A (en) * | 2005-03-31 | 2006-10-19 | Kobayashi Pharmaceut Co Ltd | Agent for periodontosis compounded with aesculus hippocastanum l. extract component |
-
2009
- 2009-07-14 JP JP2009165554A patent/JP5710111B2/en active Active
-
2010
- 2010-07-13 KR KR1020127003725A patent/KR20120042968A/en not_active Application Discontinuation
- 2010-07-13 WO PCT/JP2010/004530 patent/WO2011007551A1/en active Application Filing
- 2010-07-13 CN CN2010800297408A patent/CN102470113A/en active Pending
- 2010-07-14 TW TW099123129A patent/TW201117804A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002512966A (en) * | 1998-04-28 | 2002-05-08 | ジューズッカー アクティエンゲゼルシャフト | Cold remedy containing isomalt as active ingredient |
JP2008148614A (en) * | 2006-12-17 | 2008-07-03 | Shuhei Higashimatsu | Pudding-like food product |
JP2008283964A (en) * | 2007-04-19 | 2008-11-27 | Lion Corp | Sugar-coated chewing gum composition and method for producing sugar-coated chewing gum |
Non-Patent Citations (4)
Title |
---|
EI HASHINO ET AL.: "Erythritol ni yoru Porphyromonas gingivalis Hatsugen Tanpakushitsu no Henka ni Kansuru Morateki Kaiseki", JOURNAL OF THE JAPANESE SOCIETY OF PERIODONTOLOGY, vol. 51, 10 April 2009 (2009-04-10), pages 106 + B-3 * |
EI HASHINO ET AL.: "Erythritol wa Shishubyogensei Saikin no Kihatsusei Ryukabutsu Sansei o Yokusei suru", JOURNAL OF DENTAL HEALTH, vol. 59, no. 5, 30 October 2009 (2009-10-30), pages 608 - 609 + P12 * |
SU-JI HAN ET AL.: "Xylitol Inhibits Inflammatory Cytokine Expression Induced by Lipopolysaccharide from Porphyromonas gingivalis", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 12, no. 11, November 2005 (2005-11-01), pages 1285 - 1291, XP055241517, DOI: doi:10.1128/CDLI.12.11.1285-1291.2005 * |
YUJI KODAMA ET AL.: "Kihatsusei Io Kagobutsu no Sansei ni Oyobosu To Alcohol no Eikyo", THE 56TH PROCEEDINGS OF JAPANESE SOCIETY OF FOOD SCIENCE AND TECHNOLOGY, 10 September 2009 (2009-09-10), pages 137 - 3FP11 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015084314A1 (en) * | 2013-12-02 | 2015-06-11 | Colgate-Palmolive Company | Oral care zinc compositions |
CN106413670A (en) * | 2013-12-02 | 2017-02-15 | 高露洁-棕榄公司 | Oral care zinc compositions |
AU2013406783B2 (en) * | 2013-12-02 | 2017-08-31 | Colgate-Palmolive Company | Oral care zinc compositions |
CN111214388A (en) * | 2013-12-02 | 2020-06-02 | 高露洁-棕榄公司 | Oral care zinc compositions |
WO2015099755A1 (en) * | 2013-12-27 | 2015-07-02 | Colgate-Palmolive Company | Prebiotic oral care methods using a saccharide |
AU2013408774B2 (en) * | 2013-12-27 | 2017-06-29 | Colgate-Palmolive Company | Prebiotic oral care methods using a saccharide |
US10328010B2 (en) | 2013-12-27 | 2019-06-25 | Colgate-Palmolive Company | Prebiotic oral care methods using a saccharide |
US11419806B2 (en) | 2013-12-27 | 2022-08-23 | Colgate-Palmolive Company | Prebiotic oral care methods using a saccharide |
WO2023199057A1 (en) * | 2022-04-13 | 2023-10-19 | Brunel University London | Compositions for preventing and treating infection comprising an artificial sweetener |
Also Published As
Publication number | Publication date |
---|---|
JP2011020935A (en) | 2011-02-03 |
TW201117804A (en) | 2011-06-01 |
KR20120042968A (en) | 2012-05-03 |
JP5710111B2 (en) | 2015-04-30 |
CN102470113A (en) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101723588B1 (en) | Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof | |
US11382850B2 (en) | Compositions and methods for inhibiting growth of caries-, gingivitis- and halitosis-causing bacteria | |
JP3614479B2 (en) | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them | |
KR101156623B1 (en) | Antimicrobial agent, composition and food products for oral cavity | |
JP5710111B2 (en) | Antibacterial agent consisting of lactitol and maltitol | |
US20100129297A1 (en) | Use of an aqueous grape seed extract combined with at least one fluorine salt to combat the formation or accumulation of dental biofilm and compositions comprising said combination | |
KR102207872B1 (en) | Oral composition for preventation or treatment of oral disease | |
KR20160098669A (en) | Mouth cleaner comprising citrus or lime extract and manufacturing method thereof | |
JP7351296B2 (en) | Oral flora improving agent and oral composition | |
WO2022075481A1 (en) | Oral care composition comprising sweet potato-derived potato syrup or potato syrup supernatant | |
JP2017081831A (en) | Antimicrobial agent for oral cavities, and oral composition | |
US20220304941A1 (en) | Composition for preventing or treating oral diseases | |
JP5826449B2 (en) | Deodorant, oral composition containing the same, and food and drink | |
KR20160084904A (en) | Composition for sanitation promotion of oral cavity comprising natural medicinal ingredient extract as effective component | |
Goldfaden | Antibacterial efficacy of novel eastern medicine-inspired toothpastes compared to commercial formulations | |
WO2013001817A1 (en) | Oral bacteria proliferation inhibitor | |
US20110098495A1 (en) | Compositions and methods of omega polyunsaturated fatty acids for the treatment of oral diseases | |
RU2777153C1 (en) | Composition for oral care for patients with metabolic disorders | |
US20160346171A1 (en) | Oral composition and confection | |
KR20170094609A (en) | Manufactureing method of periodontitis prevention solution | |
JPH0434968B2 (en) | ||
Carlson et al. | Olive Oil, Oil Pulling and Dental Health | |
WO2018168821A1 (en) | Composition for use in oral cavity | |
KR20230040240A (en) | Composition for preventing a biofilm formation | |
WO2024077121A1 (en) | Oral care compositions containing rhamnolipids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080029740.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10799615 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20127003725 Country of ref document: KR Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10799615 Country of ref document: EP Kind code of ref document: A1 |